<DOC>
	<DOCNO>NCT02724267</DOCNO>
	<brief_summary>The aim study evaluate 131I-chTNT-1/B treatment effect safety individual therapy use randomize control study , order acquire evidence evidence-based medicine create new program target internal radiation therapy advance HCC patient .</brief_summary>
	<brief_title>Targeted Internal Radiation Therapy Advanced HCC Patients .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Via clinical diagnosis confirm advance hepatocellular carcinoma 2. mRECIST estimation : necrosis region HCC 3 . Negative iodine allergy test 4 . Liver function ：ChildPugh A/B 1. reject attend； 2. impossible come hospital physical examination regularly . 3 . Blood clot function hindrance ; 4 , Patients apparent cardiac , pulmonary , cerebral renal dysfunction , may affect treatment liver cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>131I-chTNT-1/B treatment</keyword>
</DOC>